B
Kamada Ltd. KMDA
$6.77 -$0.16-2.31% NASDAQ
Recommendation
Prev Close
$6.93
Volume
59,842
Avg Vol (90D)
60,409
Market Cap
$400.74M
Dividend & Yield
--
52-Week Range
$5.18 - $9.16
P/E (TTM)
20.39
EPS (TTM)
$0.34
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Kamada (NASDAQ:KMDA) Given Buy (B-) Rating at Weiss Ratings
10/10/2025 - MarketBeat
Is Kamada (KMDA) a Solid Growth Stock? 3 Reasons to Think "Yes"
10/6/2025 - Zacks Investment Research
Sidoti Csr Has Bullish Forecast for Kamada FY2025 Earnings
10/6/2025 - MarketBeat
Kamada (NASDAQ:KMDA) Stock Price Passes Below Two Hundred Day Moving Average - What's Next?
10/4/2025 - MarketBeat
Should Value Investors Buy Kamada (KMDA) Stock?
10/3/2025 - Zacks Investment Research
Kamada (KMDA, $6.69) price may climb as it broke lower Bollinger Band on Sep 25, 2025
9/26/2025 - Tickeron - Technical Analysis
Goldman Sachs Group Inc. Acquires Shares of 75,146 Kamada Ltd. $KMDA
9/26/2025 - MarketBeat
Kamada (NASDAQ:KMDA) Shares Cross Below 200-Day Moving Average - What's Next?
9/25/2025 - MarketBeat
Kamada Ltd. (NASDAQ:KMDA) Short Interest Down 25.0% in August
9/19/2025 - MarketBeat
Kamada (KMDA, $6.83) price may climb as it broke lower Bollinger Band on Sep 15, 2025
9/16/2025 - Tickeron - Stocks
KMDA Crosses Below Key Moving Average Level
9/15/2025 - Market News Video
Kamada Ltd. (NASDAQ:KMDA) Short Interest Update
9/11/2025 - MarketBeat
Kamada (NASDAQ:KMDA) Shares Pass Below 200 Day Moving Average - Here's What Happened
9/6/2025 - MarketBeat
Kamada (KMDA) is an Incredible Growth Stock: 3 Reasons Why
9/3/2025 - Zacks Investment Research
Wall Street Analysts See an 110.11% Upside in Kamada (KMDA): Can the Stock Really Move This High?
9/3/2025 - Zacks Investment Research
Halozyme Therapeutics, Inc. (HALO) Hit a 52 Week High, Can the Run Continue?
9/3/2025 - Zacks Investment Research
Kamada to Participate in Upcoming September Investor Conferences KMDA Stock News
9/2/2025 - GuruFocus
Kamada to Participate in Upcoming September Investor Conferences
9/2/2025 - GuruFocus
Kamada to Participate in Upcoming September Investor Conferences
9/2/2025 - Globe Newswire
KMDA or ARGX: Which Is the Better Value Stock Right Now?
9/1/2025 - Zacks Investment Research
Should Value Investors Buy Kamada (KMDA) Stock?
9/1/2025 - Zacks Investment Research
Kamada Ltd's Earnings Call: Positive Growth and Strategic Initiatives
9/1/2025 - TipRanks Financial Blog
Kamada: Earnings Expansion Cycle With Embedded Margin Of Safety
8/27/2025 - Seeking Alpha - Long Ideas
Kamada: Earnings Expansion Cycle With Embedded Margin Of Safety
8/27/2025 - SeekingAlpha
Kamada: Earnings Expansion Cycle With Embedded Margin Of Safety
8/27/2025 - Seeking Alpha - Israel Stocks
Income Statement
Total Revenue (TTM)
$169.52M
EBITDA (TTM)
$38.45M
EBIT (TTM)
$25.24M
Net Income (TTM)
$19.01M
Balance Sheet
Total Assets (Q)
$368.17M
Total Debt (Q)
$11.42M
Total Liabilities (Q)
$108.22M
Book Value Per Share (Q)
$4.58
Cash Flow
Cash from Operations (TTM)
$40.12M
Cash from Investing (TTM)
-$8.52M
Cash from Financing (TTM)
-$21.91M
Net Change in Cash (TTM)
$9.44M
Filings
Filing Date
Wednesday, August 13, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Loading...
Beta
0.88
7-Day Total Return
-1.02%
30-Day Total Return
-3.56%
60-Day Total Return
-8.88%
90-Day Total Return
0.59%
Year to Date Total Return
10.02%
1-Year Total Return
33.93%
2-Year Total Return
40.13%
3-Year Total Return
64.64%
5-Year Total Return
-11.62%
52-week Low
Oct 10, 2024 - $5.18
52-week High
Feb 10, 2025 - $9.16
Valuation
Market Cap
$400.74M - Small Cap
Enterprise Value
$344.57M
Price/Sales (TTM)
2.32
Price/Book (Q)
1.51
Dividends and Shares
Shares Outstanding
56.74
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.kamada.com
Phone Number
972 8 940 6472
Address
2 Holzman Street
Science Park - PO Box 4081
Rehovot, 7670402
Country
Israel
Year Founded
1990
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its products include KAMRAB/KEDRAB indicated as prophylaxis of rabies; CYTOGAM for prophylaxis of Cytomegalovirus disease... more
NASDAQ 10/10/2025 3:21PM Eastern Quotes delayed